Coeptis Therapeutics Holdings, INC. (COEP) — SEC Filings
Latest SEC filings for Coeptis Therapeutics Holdings, INC.. Recent 25-NSE filing on Apr 24, 2026. AI-decoded analysis of earnings, risk factors, and inside
View Coeptis Therapeutics Holdings, INC. on SEC EDGAR
Overview
Coeptis Therapeutics Holdings, INC. (COEP) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 424B3 filed on Mar 23, 2026: Coeptis Therapeutics Holdings, Inc. filed a 424B3 prospectus supplement on March 23, 2026, related to their existing registration statement 333-269782. This filing updates or adds information to a previous offering, indicating that the company is likely continuing to raise capital or modify terms of
Sentiment Summary
Across 3 filings, the sentiment breakdown is: 3 neutral. The dominant filing sentiment for Coeptis Therapeutics Holdings, INC. is neutral.
Filing Type Overview
Coeptis Therapeutics Holdings, INC. (COEP) has filed 1 25-NSE, 2 424B3 with the SEC between Mar 2026 to Apr 2026.
Recent Filings (3)
- 25-NSE Filing — 25-NSE · Apr 24, 2026
-
Coeptis Therapeutics Files 424B3 Prospectus Supplement
— 424B3 · Mar 23, 2026
Coeptis Therapeutics Holdings, Inc. filed a 424B3 prospectus supplement on March 23, 2026, related to their existing registration statement 333-269782. This fil -
Coeptis Therapeutics Files 424B3 Prospectus Supplement
— 424B3 · Mar 23, 2026
Coeptis Therapeutics Holdings, Inc. filed a 424B3 prospectus supplement on March 23, 2026, related to their existing registration statement (File No. 333-284230
Top Tags
prospectus (2) · capital-raise (2) · offering (2) · equity (1)
Frequently Asked Questions
What are the latest SEC filings for Coeptis Therapeutics Holdings, INC. (COEP)?
Coeptis Therapeutics Holdings, INC. has 3 recent SEC filings from Mar 2026 to Apr 2026, including 2 424B3, 1 25-NSE. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of COEP filings?
Across 3 filings, the sentiment breakdown is: 3 neutral. The dominant sentiment is neutral.
Where can I find Coeptis Therapeutics Holdings, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Coeptis Therapeutics Holdings, INC. (COEP) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Coeptis Therapeutics Holdings, INC.?
Financial highlights for Coeptis Therapeutics Holdings, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for COEP?
Investment thesis data for COEP will be available once enriched filings are processed.
Who are the key executives at Coeptis Therapeutics Holdings, INC.?
Executive information for Coeptis Therapeutics Holdings, INC. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Coeptis Therapeutics Holdings, INC. stock?
Risk factor analysis for Coeptis Therapeutics Holdings, INC. is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Coeptis Therapeutics Holdings, INC.?
Forward guidance and predictions for Coeptis Therapeutics Holdings, INC. are extracted from SEC filings as they are enriched.